Subsequently, we performed immunoprecipitation assays of whole-cell lysates from patient-derived CRC-SCs and confirmed that SMYD3 co-immunoprecipitates with c-MYC in these models (Fig. 3a). This evidence concerns the gene SMYD3 and colorectal carcinoma.